Showing 1,661 - 1,680 results of 23,283 for search '(( 2 step decrease ) OR ( 100 ((((we decrease) OR (a decrease))) OR (mean decrease)) ))', query time: 1.13s Refine Results
  1. 1661

    GLS analysis with 2D-STE software. by Chantelle M. de Vet (16535257)

    Published 2024
    “…</p><p>Conclusions</p><p>A clear learning effect was observed by the significant decrease in variability of the difference in the score between the expert and trainees over time. …”
  2. 1662
  3. 1663
  4. 1664
  5. 1665
  6. 1666
  7. 1667
  8. 1668

    Data Sheet 5_Liver X receptor agonist T0901317 alleviates sepsis-induced acute lung injury by enhancing macrophage autophagy.csv by Ben Wang (250897)

    Published 2025
    “…Following S100A8 knockdown in the macrophages with S100A8-siRNA, the IL-6 expression was noted to decrease in cells treated with T0+LPS+S100A8-siRNA than those treated with LPS+T0. …”
  9. 1669

    Data Sheet 2_Liver X receptor agonist T0901317 alleviates sepsis-induced acute lung injury by enhancing macrophage autophagy.csv by Ben Wang (250897)

    Published 2025
    “…Following S100A8 knockdown in the macrophages with S100A8-siRNA, the IL-6 expression was noted to decrease in cells treated with T0+LPS+S100A8-siRNA than those treated with LPS+T0. …”
  10. 1670

    Image 4_Liver X receptor agonist T0901317 alleviates sepsis-induced acute lung injury by enhancing macrophage autophagy.tif by Ben Wang (250897)

    Published 2025
    “…Following S100A8 knockdown in the macrophages with S100A8-siRNA, the IL-6 expression was noted to decrease in cells treated with T0+LPS+S100A8-siRNA than those treated with LPS+T0. …”
  11. 1671

    Image 3_Liver X receptor agonist T0901317 alleviates sepsis-induced acute lung injury by enhancing macrophage autophagy.tif by Ben Wang (250897)

    Published 2025
    “…Following S100A8 knockdown in the macrophages with S100A8-siRNA, the IL-6 expression was noted to decrease in cells treated with T0+LPS+S100A8-siRNA than those treated with LPS+T0. …”
  12. 1672

    Data Sheet 1_Liver X receptor agonist T0901317 alleviates sepsis-induced acute lung injury by enhancing macrophage autophagy.csv by Ben Wang (250897)

    Published 2025
    “…Following S100A8 knockdown in the macrophages with S100A8-siRNA, the IL-6 expression was noted to decrease in cells treated with T0+LPS+S100A8-siRNA than those treated with LPS+T0. …”
  13. 1673

    Image 1_Liver X receptor agonist T0901317 alleviates sepsis-induced acute lung injury by enhancing macrophage autophagy.tif by Ben Wang (250897)

    Published 2025
    “…Following S100A8 knockdown in the macrophages with S100A8-siRNA, the IL-6 expression was noted to decrease in cells treated with T0+LPS+S100A8-siRNA than those treated with LPS+T0. …”
  14. 1674

    Image 2_Liver X receptor agonist T0901317 alleviates sepsis-induced acute lung injury by enhancing macrophage autophagy.tif by Ben Wang (250897)

    Published 2025
    “…Following S100A8 knockdown in the macrophages with S100A8-siRNA, the IL-6 expression was noted to decrease in cells treated with T0+LPS+S100A8-siRNA than those treated with LPS+T0. …”
  15. 1675

    Data Sheet 4_Liver X receptor agonist T0901317 alleviates sepsis-induced acute lung injury by enhancing macrophage autophagy.csv by Ben Wang (250897)

    Published 2025
    “…Following S100A8 knockdown in the macrophages with S100A8-siRNA, the IL-6 expression was noted to decrease in cells treated with T0+LPS+S100A8-siRNA than those treated with LPS+T0. …”
  16. 1676

    Data Sheet 3_Liver X receptor agonist T0901317 alleviates sepsis-induced acute lung injury by enhancing macrophage autophagy.csv by Ben Wang (250897)

    Published 2025
    “…Following S100A8 knockdown in the macrophages with S100A8-siRNA, the IL-6 expression was noted to decrease in cells treated with T0+LPS+S100A8-siRNA than those treated with LPS+T0. …”
  17. 1677
  18. 1678
  19. 1679
  20. 1680

    Therapeutic Targeting of Tumor Growth and Angiogenesis with a Novel Anti-S100A4 Monoclonal Antibody by Jose Luis Hernández (453962)

    Published 2013
    “…Based on these results we developed 5C3, a neutralizing monoclonal antibody against S100A4. …”